JPY 2231.0
(-0.4%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 12.71 Billion JPY | -13.17% |
2022 | 14.64 Billion JPY | -15.47% |
2021 | 17.32 Billion JPY | 26.47% |
2020 | 13.69 Billion JPY | 11.03% |
2019 | 12.33 Billion JPY | -3.42% |
2018 | 12.77 Billion JPY | -6.64% |
2017 | 13.68 Billion JPY | -0.33% |
2016 | 13.72 Billion JPY | -4.31% |
2015 | 14.34 Billion JPY | 6.08% |
2014 | 13.52 Billion JPY | -12.66% |
2013 | 15.48 Billion JPY | -10.44% |
2012 | 17.29 Billion JPY | 2.39% |
2011 | 16.88 Billion JPY | 2.58% |
2010 | 16.46 Billion JPY | 0.0% |
2009 | - JPY | -100.0% |
2008 | 11.79 Billion JPY | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 3.21 Billion JPY | 0.28% |
2023 Q4 | 3.2 Billion JPY | -1.96% |
2023 Q3 | 3.27 Billion JPY | -1.95% |
2023 Q2 | 3.33 Billion JPY | 7.37% |
2023 Q1 | 3.1 Billion JPY | -6.87% |
2023 FY | 12.71 Billion JPY | -13.17% |
2022 FY | 14.64 Billion JPY | -15.47% |
2022 Q3 | 3.64 Billion JPY | -9.97% |
2022 Q1 | 3.6 Billion JPY | -26.17% |
2022 Q2 | 4.05 Billion JPY | 12.27% |
2022 Q4 | 3.33 Billion JPY | -8.58% |
2021 Q3 | 3.61 Billion JPY | -22.25% |
2021 Q1 | 4.16 Billion JPY | 7.81% |
2021 FY | 17.32 Billion JPY | 26.47% |
2021 Q2 | 4.65 Billion JPY | 11.56% |
2021 Q4 | 4.88 Billion JPY | 35.18% |
2020 Q3 | 3.69 Billion JPY | 6.21% |
2020 Q2 | 3.47 Billion JPY | 30.94% |
2020 Q4 | 3.86 Billion JPY | 4.65% |
2020 FY | 13.69 Billion JPY | 11.03% |
2020 Q1 | 2.65 Billion JPY | -12.02% |
2019 Q3 | 2.95 Billion JPY | -8.01% |
2019 Q1 | 3.15 Billion JPY | 9.02% |
2019 FY | 12.33 Billion JPY | -3.42% |
2019 Q4 | 3.02 Billion JPY | 2.27% |
2019 Q2 | 3.21 Billion JPY | 1.78% |
2018 Q3 | 3.37 Billion JPY | 5.04% |
2018 FY | 12.77 Billion JPY | -6.64% |
2018 Q4 | 2.89 Billion JPY | -14.28% |
2018 Q2 | 3.21 Billion JPY | -2.43% |
2018 Q1 | 3.29 Billion JPY | 0.24% |
2017 Q4 | 3.28 Billion JPY | -4.12% |
2017 Q1 | 3.53 Billion JPY | 9.0% |
2017 Q3 | 3.42 Billion JPY | -0.26% |
2017 Q2 | 3.43 Billion JPY | -2.88% |
2017 FY | 13.68 Billion JPY | -0.33% |
2016 Q4 | 3.24 Billion JPY | -6.51% |
2016 Q2 | 3.54 Billion JPY | 1.96% |
2016 Q3 | 3.47 Billion JPY | -1.95% |
2016 Q1 | 3.47 Billion JPY | -1.11% |
2016 FY | 13.72 Billion JPY | -4.31% |
2015 Q1 | 3.61 Billion JPY | 10.55% |
2015 Q3 | 3.78 Billion JPY | 10.03% |
2015 Q2 | 3.43 Billion JPY | -4.9% |
2015 FY | 14.34 Billion JPY | 6.08% |
2015 Q4 | 3.51 Billion JPY | -7.19% |
2014 Q3 | 3.43 Billion JPY | -1.24% |
2014 Q4 | 3.27 Billion JPY | -4.69% |
2014 FY | 13.52 Billion JPY | -12.66% |
2014 Q1 | 3.35 Billion JPY | 13.95% |
2014 Q2 | 3.47 Billion JPY | 3.7% |
2013 Q2 | 4.11 Billion JPY | -5.88% |
2013 FY | 15.48 Billion JPY | -10.44% |
2013 Q1 | 4.36 Billion JPY | -5.29% |
2013 Q3 | 4.06 Billion JPY | -1.07% |
2013 Q4 | 2.94 Billion JPY | -27.71% |
2012 Q3 | 4.23 Billion JPY | 2.27% |
2012 FY | 17.29 Billion JPY | 2.39% |
2012 Q2 | 4.14 Billion JPY | -3.63% |
2012 Q1 | 4.29 Billion JPY | 14.67% |
2012 Q4 | 4.61 Billion JPY | 8.85% |
2011 FY | 16.88 Billion JPY | 2.58% |
2011 Q2 | 4.29 Billion JPY | -2.43% |
2011 Q4 | 3.74 Billion JPY | -15.7% |
2011 Q3 | 4.44 Billion JPY | 3.61% |
2011 Q1 | 4.39 Billion JPY | 8.22% |
2010 FY | 16.46 Billion JPY | 0.0% |
2010 Q3 | 4.24 Billion JPY | 2.46% |
2010 Q2 | 4.13 Billion JPY | 3.04% |
2010 Q1 | 4.01 Billion JPY | 0.0% |
2010 Q4 | 4.06 Billion JPY | -4.15% |
2009 Q3 | 3.04 Billion JPY | 0.0% |
2009 FY | - JPY | -100.0% |
2009 Q4 | - JPY | -100.0% |
2008 Q3 | 3.23 Billion JPY | 0.0% |
2008 Q4 | 2.65 Billion JPY | -17.88% |
2008 FY | 11.79 Billion JPY | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 14.28 Billion JPY | 10.968% |
DNA Chip Research Inc. | 66.35 Million JPY | -19064.167% |
Cosmo Bio Company,Limited | 3.25 Billion JPY | -291.262% |
H.U. Group Holdings, Inc. | 63.23 Billion JPY | 79.891% |
BML, Inc. | 45.62 Billion JPY | 72.132% |
Human Metabolome Technologies, Inc. | 869.33 Million JPY | -1362.732% |
Precision System Science Co., Ltd. | 950.37 Million JPY | -1237.995% |